Citation 83219

SHIN,JH: SEO,YW: CHO,KW: MOON,SS: CHO,YJ:. (1999). EUPLEXIDES A - E: NOVEL FARNESYLHYDROQUINONE GLYCOSIDES FROM THE GORGONIAN EUPLEXAURA ANASTOMOSANS.. 64(6)

Citation Details

Title	EUPLEXIDES A - E: NOVEL FARNESYLHYDROQUINONE GLYCOSIDES FROM THE GORGONIAN EUPLEXAURA ANASTOMOSANS.
Authors	SHIN,JH: SEO,YW: CHO,KW: MOON,SS: CHO,YJ:
Year	1999
Volume	64
Issue	6

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (1)

Euplexaura anastomosans (PLEXAURIDAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	EUPLEXIDE A	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	WEAK ACTIVITY
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	WEAK ACTIVITY
4	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	EUPLEXIDE A	ACTIVE
7	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPLEXIDE A	ACTIVE
8	PHOSPHOLIPASE A2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPLEXIDE A	ACTIVE
9	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	EUPLEXIDE B	None
10	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	EUPLEXIDE C	None
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	EUPLEXIDE B	ACTIVE
12	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPLEXIDE B	ACTIVE
13	PHOSPHOLIPASE A2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPLEXIDE B	ACTIVE
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	EUPLEXIDE C	ACTIVE
15	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPLEXIDE C	ACTIVE
16	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	EUPLEXIDE D	None
17	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	EUPLEXIDE E	None
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	EUPLEXIDE D	ACTIVE
19	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPLEXIDE D	ACTIVE
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	EUPLEXIDE E	ACTIVE
21	SUPEROXIDE DISMUTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPLEXIDE E	ACTIVE

Citation 83219

Citation Details

Summary

Organisms and Their Experiments (1)

Euplexaura anastomosans (PLEXAURIDAE)

Show SPARQL Queries (1)

Query 1